Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | DRD2 | P14416 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR7 | P34969 | 1/20 | 0.52 |
| ▸ | HTR6 | P50406 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8563297 | 1.00 | KCNH2 (0.52) | KCNH2HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL8561891 | 0.83 | DRD2 (0.56) | HTR1ADRD2HTR2AHTR7HTR6 | |
| SCHEMBL8567026 | 0.83 | DRD2 (0.56) | HTR1ADRD2HTR2AHTR7HTR6 | |
| SCHEMBL8561885 | 0.83 | DRD2 (0.56) | HTR1ADRD2HTR2AHTR7HTR6 | |
| SCHEMBL2318212 | 0.81 | ADRA1B (0.66) | HTR1A | |
| SCHEMBL2316840 | 0.81 | ADRA1B (0.66) | HTR1A | |
| SCHEMBL2316845 | 0.81 | ADRA1B (0.66) | HTR1A | |
| SCHEMBL10835969 | 0.81 | HTR1A (0.76) | KCNH2HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL21802143 | 0.81 | HTR1A (0.76) | KCNH2HTR1ADRD2HTR2AHTR7 | |
| SCHEMBL3081051 | 0.80 | KCNH2 (0.58) | KCNH2HTR1AHTR2AHTR7HTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0494604-B1 | 1-Piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments | HOECHST MARION ROUSSEL INC (US) | 1998-10-07 | — | — | EP | disclosed |
| US-5440048-A | Treating psychoses | HOECHST-ROUSSEL PHARMACEUTICALS INC (US) | 1995-08-08 | — | — | US | disclosed |
| US-5334715-A | For treating psychological disorders | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1994-08-02 | — | — | US | disclosed |
| US-5194436-A | For trating psychosis | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1993-03-16 | — | — | US | disclosed |
| EP-0494604-A1 | 1-Piperazinyl-2-butenes and 2-butynes, intermediates thereof, a process for their preparation and their use as medicaments | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1992-07-15 | — | — | EP | disclosed |
| US-5130315-A | Treatment of psychosis | Wittekind, Raymond R. (US) | 1992-07-14 | — | — | US | disclosed |